References
- Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 30:931-933, 2000 https://doi.org/10.1086/313792
- Faulkner CM, Cox HL, Williamson JC. Unique aspects of antimicrobial use in older adults. Clin Infect Dis 40:997-1004, 2005 https://doi.org/10.1086/428125
- Marangos MN, Skoutelis AT, Nightingale CH, Zhu Z, Psyrogiannis AG, Nicolau DP, Bassaris HP, Quintiliani R. Absorption of ciprofloxacin in patients with diabetic gastroparesis. Antimicrob Agents Chemother 39:2161-2163, 1995 https://doi.org/10.1128/AAC.39.9.2161
- Greenblatt DJ, Sellers EM, Shader RI. Drug therapy: drug disposition in old age. N Engl J Med 306:1081-1088, 1982 https://doi.org/10.1056/NEJM198205063061804
- Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155-163, 1976 https://doi.org/10.1093/geronj/31.2.155
- McCusker J, Cole M, Dendukuri N, Belzile E, Primeau F. Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. CMAJ 165:575-583, 2001
- Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809-817, 2002 https://doi.org/10.1016/S0895-4356(02)00411-0
- Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35:1004-1009, 2001 https://doi.org/10.1345/aph.10351
- Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161:1629-1634, 2001 https://doi.org/10.1001/archinte.161.13.1629
- Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2:659-666, 2002 https://doi.org/10.1016/S1473-3099(02)00437-1
- Nicholson SC, High KP, Gothelf S, Webb CD. Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly. Diagn Microbiol Infect Dis 44:109-116, 2002 https://doi.org/10.1016/S0732-8893(02)00458-3
- van den Brande P, van Steenbergen W, Vervoort G, Demedts M. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 152:1705-1708, 1995 https://doi.org/10.1164/ajrccm.152.5.7582317
- Baciewicz AM, Sokos DR, Cowan RI. Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother 37:182-186, 2003 https://doi.org/10.1345/aph.1A395
- Gatell JM, Ferran F, Araujo V, Bonet M, Soriano E, Traserra J, SanMiguel JG. Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother 31:1383-1387, 1987 https://doi.org/10.1128/AAC.31.9.1383
- Weber S, Mawdsley E, Kaye D. Antibacterial agents in the elderly. Infect Dis Clin North Am 23:881-898, viii, 2009 https://doi.org/10.1016/j.idc.2009.06.012